Aidoc, an AI company that helps medical teams make real-time clinical decisions, has raised $150 million at a valuation higher than its previous round, bringing its total funding to $370 million to date. The latest funding round marks a significant milestone for the company, with NVentures, NVIDIA’s investment arm, joining as an investor for the first time. The round was co-led by General Catalyst and Square Peg, alongside several major U.S. health systems. Approximately $40 million of the funding was raised through a revolving credit facility. The capital will be used to accelerate the development of CARE, Aidoc’s new Foundation Model, which underpins two AI products recently approved by the FDA and adds to dozens of prior approvals. In an interview with Calcalist, Michael Braginsky, Aidoc’s CTO, said: “We saw an opportunity with our new technology to move faster. With our previous technology, we tackled one disease at a time. Now, the mapping rate is significantly faster. What used to take decades now takes far less time, we can build each algorithm ten times faster. We used to develop one or two algorithms a year; this year alone, we’ve created fifteen, providing doctors with more comprehensive insights into patient conditions. Revenue from the new technology already surpasses everything we’ve done in recent years. Within a year, we expect to exceed the total of the last nine years.”

Full report : Aidoc, which uses AI to help doctors make real-time clinical decisions, raised $150 million led by General Catalyst and Square Peg, bringing its total funding to $370 million.